318 related articles for article (PubMed ID: 14499735)
41. Differential induction of apoptosis of leukemic cells by rhizochalin, two headed sphingolipids from sponge and its derivatives.
Jin JO; Shastina V; Park JI; Han JY; Makarieva T; Fedorov S; Rasskazov V; Stonik V; Kwak JY
Biol Pharm Bull; 2009 Jun; 32(6):955-62. PubMed ID: 19483298
[TBL] [Abstract][Full Text] [Related]
42. A novel jaspine B-ceramide hybrid modulates sphingolipid metabolism.
Garcia V; Le Faouder P; Dupuy A; Levade T; Ballereau S; Génisson Y
Chem Biodivers; 2015 Jul; 12(7):1115-25. PubMed ID: 26172331
[TBL] [Abstract][Full Text] [Related]
43. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
Sullards MC; Wang E; Peng Q; Merrill AH
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):789-97. PubMed ID: 14528916
[TBL] [Abstract][Full Text] [Related]
44. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.
Mignard V; Dubois N; Lanoé D; Joalland MP; Oliver L; Pecqueur C; Heymann D; Paris F; Vallette FM; Lalier L
J Lipid Res; 2020 Jul; 61(7):1025-1037. PubMed ID: 32350079
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of synthetic sphingosine, lysosphingolipids and glycosphingolipids as inhibitors of functional responses of human neutrophils.
Fiore S; Nicolaou KC; Caulfield T; Kataoka H; Serhan CN
Biochem J; 1990 Feb; 266(1):25-31. PubMed ID: 2155608
[TBL] [Abstract][Full Text] [Related]
46. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine.
Wieder T; Orfanos CE; Geilen CC
J Biol Chem; 1998 May; 273(18):11025-31. PubMed ID: 9556584
[TBL] [Abstract][Full Text] [Related]
47. The chemistry and biology of 6-hydroxyceramide, the youngest member of the human sphingolipid family.
Kováčik A; Roh J; Vávrová K
Chembiochem; 2014 Jul; 15(11):1555-62. PubMed ID: 24990520
[TBL] [Abstract][Full Text] [Related]
48. Ceramide transfer protein and cancer.
Scheffer L; Raghavendra PR; Ma J; Acharya JK
Anticancer Agents Med Chem; 2011 Nov; 11(9):904-10. PubMed ID: 21707482
[TBL] [Abstract][Full Text] [Related]
49. Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency.
Kang JH; Garg H; Sigano DM; Francella N; Blumenthal R; Marquez VE
Bioorg Med Chem; 2009 Feb; 17(4):1498-505. PubMed ID: 19171486
[TBL] [Abstract][Full Text] [Related]
50. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
[TBL] [Abstract][Full Text] [Related]
51. Cell-permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-alpha-receptors by inducing G0/G1 arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis.
Kuroki J; Hirokawa M; Kitabayashi A; Lee M; Horiuchi T; Kawabata Y; Miura AB
Leukemia; 1996 Dec; 10(12):1950-8. PubMed ID: 8946936
[TBL] [Abstract][Full Text] [Related]
52. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
[TBL] [Abstract][Full Text] [Related]
53. 1-Methylthiodihydroceramide, a novel analog of dihydroceramide, stimulates sphinganine degradation resulting in decreased de novo sphingolipid biosynthesis.
van Echten-Deckert G; Giannis A; Schwarz A; Futerman AH; Sandhoff K
J Biol Chem; 1998 Jan; 273(2):1184-91. PubMed ID: 9422785
[TBL] [Abstract][Full Text] [Related]
54. Sphingolipids related to apoptosis from the point of view of membrane structure and topology.
van Blitterswijk WJ; van der Luit AH; Caan W; Verheij M; Borst J
Biochem Soc Trans; 2001 Nov; 29(Pt 6):819-24. PubMed ID: 11709081
[TBL] [Abstract][Full Text] [Related]
55. Sphingosine-induced c-jun expression: differences between sphingosine- and C2-ceramide-mediated signaling pathways.
Sawai H; Okazaki T; Domae N
FEBS Lett; 2002 Jul; 524(1-3):103-6. PubMed ID: 12135749
[TBL] [Abstract][Full Text] [Related]
56. Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
Morad SA; Tan SF; Feith DJ; Kester M; Claxton DF; Loughran TP; Barth BM; Fox TE; Cabot MC
Biochim Biophys Acta; 2015 Jul; 1851(7):919-28. PubMed ID: 25769964
[TBL] [Abstract][Full Text] [Related]
57. Dihydroceramide biology. Structure-specific metabolism and intracellular localization.
Kok JW; Nikolova-Karakashian M; Klappe K; Alexander C; Merrill AH
J Biol Chem; 1997 Aug; 272(34):21128-36. PubMed ID: 9261117
[TBL] [Abstract][Full Text] [Related]
58. Induction of programmed cell death and immunosuppression by exogenous sphingolipids are separate processes.
Olshefski R; Taylor B; Heitger A; Hasegawa A; Ladisch S
Eur J Biochem; 1996 Oct; 241(1):47-55. PubMed ID: 8898887
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
60. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
